Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 26758 | 246 | 31.4 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
| 118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
| 109 | 2 | CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA | 25223 |
| 26758 | 1 | BENDAMUSTINE//TREANDA//BENDAMUSTIN | 246 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BENDAMUSTINE | authKW | 9015901 | 57% | 52% | 139 |
| 2 | TREANDA | authKW | 496509 | 2% | 100% | 4 |
| 3 | BENDAMUSTIN | authKW | 372382 | 1% | 100% | 3 |
| 4 | GLOBAL NONCLIN DMPK | address | 372382 | 1% | 100% | 3 |
| 5 | R BAC | authKW | 248255 | 1% | 100% | 2 |
| 6 | TREANDA R | authKW | 248255 | 1% | 100% | 2 |
| 7 | BENDAMUSTINE HYDROCHLORIDE | authKW | 223427 | 1% | 60% | 3 |
| 8 | INDOLENT B CELL NON HODGKIN LYMPHOMA | authKW | 165502 | 1% | 67% | 2 |
| 9 | 17P CLL | authKW | 124127 | 0% | 100% | 1 |
| 10 | AZIENDA OSPED UNIV CITTA SALUTE | address | 124127 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 2631 | 53% | 0% | 131 |
| 2 | Hematology | 2359 | 30% | 0% | 74 |
| 3 | Pharmacology & Pharmacy | 269 | 21% | 0% | 52 |
| 4 | Chemistry, Medicinal | 48 | 5% | 0% | 12 |
| 5 | Chemistry, Analytical | 23 | 6% | 0% | 14 |
| 6 | Biochemical Research Methods | 16 | 4% | 0% | 9 |
| 7 | Medicine, General & Internal | 8 | 4% | 0% | 11 |
| 8 | Medicine, Research & Experimental | 2 | 2% | 0% | 6 |
| 9 | Nursing | 2 | 1% | 0% | 2 |
| 10 | Toxicology | 2 | 2% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | GLOBAL NONCLIN DMPK | 372382 | 1% | 100% | 3 |
| 2 | AZIENDA OSPED UNIV CITTA SALUTE | 124127 | 0% | 100% | 1 |
| 3 | CLIN TRIALS NETWORK OFF | 124127 | 0% | 100% | 1 |
| 4 | E GERMAN STUDY GRP HEMATOL ONCOL | 124127 | 0% | 100% | 1 |
| 5 | EMATOL AZIENDA OSPED | 124127 | 0% | 100% | 1 |
| 6 | ERV HEMATOL CLIN | 124127 | 0% | 100% | 1 |
| 7 | FRAUENKLIN VINCENTIUS KLINIKEN | 124127 | 0% | 100% | 1 |
| 8 | HEMATOL BMTT | 124127 | 0% | 100% | 1 |
| 9 | HOSP CLINHEMATOPATHOL UNIT | 124127 | 0% | 100% | 1 |
| 10 | IMMUNPHARMAKOL | 124127 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 7458 | 7% | 0% | 17 |
| 2 | LEUKEMIA & LYMPHOMA | 7205 | 9% | 0% | 21 |
| 3 | ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM | 2545 | 2% | 1% | 4 |
| 4 | ONKOLOGIE | 2339 | 3% | 0% | 7 |
| 5 | EXPERT REVIEW OF HEMATOLOGY | 2051 | 1% | 1% | 3 |
| 6 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1680 | 4% | 0% | 10 |
| 7 | SEMINARS IN HEMATOLOGY | 1627 | 2% | 0% | 5 |
| 8 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1462 | 1% | 0% | 3 |
| 9 | ANTI-CANCER DRUGS | 1361 | 2% | 0% | 6 |
| 10 | CURRENT ONCOLOGY | 1315 | 1% | 0% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BENDAMUSTINE | 9015901 | 57% | 52% | 139 | Search BENDAMUSTINE | Search BENDAMUSTINE |
| 2 | TREANDA | 496509 | 2% | 100% | 4 | Search TREANDA | Search TREANDA |
| 3 | BENDAMUSTIN | 372382 | 1% | 100% | 3 | Search BENDAMUSTIN | Search BENDAMUSTIN |
| 4 | R BAC | 248255 | 1% | 100% | 2 | Search R+BAC | Search R+BAC |
| 5 | TREANDA R | 248255 | 1% | 100% | 2 | Search TREANDA+R | Search TREANDA+R |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 223427 | 1% | 60% | 3 | Search BENDAMUSTINE+HYDROCHLORIDE | Search BENDAMUSTINE+HYDROCHLORIDE |
| 7 | INDOLENT B CELL NON HODGKIN LYMPHOMA | 165502 | 1% | 67% | 2 | Search INDOLENT+B+CELL+NON+HODGKIN+LYMPHOMA | Search INDOLENT+B+CELL+NON+HODGKIN+LYMPHOMA |
| 8 | 17P CLL | 124127 | 0% | 100% | 1 | Search 17P+CLL | Search 17P+CLL |
| 9 | BENDAMUSTINE AND DEXAMETHASONE | 124127 | 0% | 100% | 1 | Search BENDAMUSTINE+AND+DEXAMETHASONE | Search BENDAMUSTINE+AND+DEXAMETHASONE |
| 10 | BENDAMUSTINE BORTEZOMIB DEXAMETHASONE | 124127 | 0% | 100% | 1 | Search BENDAMUSTINE+BORTEZOMIB+DEXAMETHASONE | Search BENDAMUSTINE+BORTEZOMIB+DEXAMETHASONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KORYCKA-WOLOWIEC, A , ROBAK, T , (2012) PHARMACOKINETIC EVALUATION AND THERAPEUTIC ACTIVITY OF BENDAMUSTINE IN B-CELL LYMPHOID MALIGNANCIES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 8. ISSUE 11. P. 1455 -1468 | 53 | 85% | 6 |
| 2 | PLENIS, A , FROLOW, A , REKOWSKA, N , OLEDZKA, I , KOWALSKI, P , BIEN, E , KRAWCZYK, MA , ADAMKIEWICZ-DROZYNSKA, E , BACZEK, T , (2016) DETERMINATION OF BENDAMUSTINE IN HUMAN PLASMA AND URINE BY LC-FL METHODS: APPLICATION IN A DRUG MONITORING.CHROMATOGRAPHIA. VOL. 79. ISSUE 13-14. P. 861 -873 | 30 | 97% | 0 |
| 3 | DENNIE, TW , KOLESAR, JM , (2009) BENDAMUSTINE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND RITUXIMAB-REFRACTORY, INDOLENT B-CELL NON-HODGKIN LYMPHOMA.CLINICAL THERAPEUTICS. VOL. 31. ISSUE . P. 2290 -2311 | 41 | 73% | 15 |
| 4 | CHESON, BD , RUMMEL, MJ , (2009) BENDAMUSTINE: REBIRTH OF AN OLD DRUG.JOURNAL OF CLINICAL ONCOLOGY. VOL. 27. ISSUE 9. P. 1492-1501 | 36 | 68% | 102 |
| 5 | MONTILLO, M , RICCI, F , TEDESCHI, A , VISMARA, E , MORRA, E , (2010) BENDAMUSTINE: NEW PERSPECTIVE FOR AN OLD DRUG IN LYMPHOPROLIFERATIVE DISORDERS.EXPERT REVIEW OF HEMATOLOGY. VOL. 3. ISSUE 2. P. 131-148 | 30 | 94% | 2 |
| 6 | RASSCHAERT, M , SCHRIJVERS, D , VAN DEN BRANDE, J , DYCK, J , BOSMANS, J , MERKLE, K , VERMORKEN, JB , (2007) A PHASE 1 STUDY OF BENDAMUSTINE HYDROCHLORIDE ADMINISTERED DAY 1+2 EVERY 3 WEEKS IN PATIENTS WITH SOLID TUMOURS.BRITISH JOURNAL OF CANCER. VOL. 96. ISSUE 11. P. 1692-1698 | 27 | 96% | 24 |
| 7 | GARNOCK-JONES, KP , (2010) BENDAMUSTINE A REVIEW OF ITS USE IN THE MANAGEMENT OF INDOLENT NON-HODGKIN'S LYMPHOMA AND MANTLE CELL LYMPHOMA.DRUGS. VOL. 70. ISSUE 13. P. 1703-1718 | 28 | 85% | 13 |
| 8 | CHESON, BD , BRUGGER, W , DAMAJ, G , DREYLING, M , KAHL, B , KIMBY, E , OGURA, M , WEIDMANN, E , WENDTNER, CM , ZINZANI, PL , (2016) OPTIMAL USE OF BENDAMUSTINE IN HEMATOLOGIC DISORDERS: TREATMENT RECOMMENDATIONS FROM AN INTERNATIONAL CONSENSUS PANEL - AN UPDATE.LEUKEMIA & LYMPHOMA. VOL. 57. ISSUE 4. P. 766 -782 | 33 | 49% | 3 |
| 9 | ELEFANTE, A , CZUCZMAN, MS , (2010) BENDAMUSTINE FOR THE TREATMENT OF INDOLENT NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 67. ISSUE 9. P. 713-723 | 25 | 86% | 5 |
| 10 | EICHBAUM, M , BISCHOFS, E , NEHLS, K , SCHNEEWEISS, A , SOHN, C , (2009) BENDAMUSTINE HYDROCHLORIDE - A RENAISSANCE OF ALKYLATING STRATEGIES IN ANTICANCER MEDICINE.DRUGS OF TODAY. VOL. 45. ISSUE 6. P. 431-444 | 24 | 89% | 3 |
Classes with closest relation at Level 1 |